Brighter enters the next phase of its Actiste market introduction in Nigeria and Ghana
Brighter AB (publ) (“the Company”) has, as part of the ongoing efforts to introduce Actiste® and Actiste® Mini in Nigeria and Ghana through the distributor agreements announced on December 30 2020, in collaboration with the distributors engaged a local agent. This agent will manage the market approval process and other related permits going forward. It is estimated that formal submission of complete applications with the relevant authorities will be made at the beginning of March 2021, and the processes are estimated to take approximately 6 (Ghana) and 9 (Nigeria) months, respectively.
The stated time frames are estimates and similar processes that Brighter has conducted in other jurisdictions have proceeded both faster and slower than originally expected. Updates on how the process is progressing will be presented on an ongoing basis. Moreover, the practical work related to planning and market preparations has been initiated with the distributors.
“The collaboration with the distributors has started off well and we are glad to see their commitment to introduce the Actiste portfolio to their respective countries. Now, together with the new local agent, we can confidently take further steps forward in the regulatory matters,” says Christer Trägårdh, acting CEO of Brighter.
For further information, please contact:
Brighter Investor Relations
IR@brighter.se
Christer Trägårdh, Acting CEO Brighter
christer.tragardh@brighter.se
Certified Adviser
Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 10, adviser@eminova.se, www.eminova.se.
About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.